Literature DB >> 8670005

Guillain-Barré syndrome: an unusual complication after snake bite.

T Y Chuang1, S W Lin, R C Chan.   

Abstract

The mortality rate of the Formosan krait bite has been reported to be 23%; death is from respiratory paralysis caused by neuromuscular junctions being blocked by bungarotoxin. This article presents the first case report of Guillain-Barré syndrome after snake envenomization. The patient presented with symmetric paresis and sensory signs in the upper and lower limbs, autonomic dysfunction, facial nerve involvement, and mild elevated cerebrospinal fluid protein at about 4 weeks after the bite. Electrodiagnostic studies revealed profound sensory and motor polyneuropathy. Repeated electrophysiologic findings confirmed nerve regeneration. The patient reached satisfactory functional outcome after a short-term intensive rehabilitation program despite severe axonal degeneration. This article also discusses the possible mechanism of immunopathogenesis of Guillain-Barré syndrome after krait bite.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670005     DOI: 10.1016/s0003-9993(96)90018-0

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Guillain-Barré syndrome following snake bite: An unusual complication.

Authors:  Abhishek Srivastava; A B Taly; Anupam Gupta; Aumir Moin; T Murali
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

2.  Guillain-Barre Syndrome Following a Snakebite: A Case Report and Review of Literature.

Authors:  Sajid Hameed; Mubashar Memon; Sara Khan
Journal:  Cureus       Date:  2019-07-30

Review 3.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

4.  Case report: acute demyelinating encephalomyelitis following viper bite.

Authors:  Anyi Xu; Renfei Shan; Daochao Huang; Jiajia Zhou; Anaswasseem Keenoo; Jie Qin
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.